Cargando…
Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia
INTRODUCTION: A combination of gene and cell therapies has the potential to significantly enhance the therapeutic value of mesenchymal stem cells (MSCs). The development of efficient gene delivery methods is essential if MSCs are to be of benefit using such an approach. Achieving high levels of tran...
Autores principales: | McGinley, Lisa, McMahon, Jill, Strappe, Padraig, Barry, Frank, Murphy, Mary, O'Toole, Daniel, O'Brien, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226283/ https://www.ncbi.nlm.nih.gov/pubmed/21385372 http://dx.doi.org/10.1186/scrt53 |
Ejemplares similares
-
Gene Modification of Mesenchymal Stem Cells and Articular Chondrocytes to Enhance Chondrogenesis
por: Gurusinghe, Saliya, et al.
Publicado: (2014) -
Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury
por: Shortiss, Ciara, et al.
Publicado: (2021) -
Clinical use of lentiviral vectors
por: Milone, Michael C., et al.
Publicado: (2018) -
Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage
por: Strappe, Padraig M, et al.
Publicado: (2005) -
Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)